Press Releases
Press Release filters
Sign up to receive updates from mdxhealth
Click the button below to fill in your contact information and receive updates from mdxhealth.
MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 13, 2023, 4:00 PM ET / 22:00 CET MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023
NEWS RELEASE – REGULATED INFORMATION8 NOVEMBER 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended
MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET MDxHealth Announces the Approval by its Shareholders of the
MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8
NEWS RELEASE25 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 Company to
MDxHealth Reports Preliminary Q3-2023 Revenues
NEWS RELEASE – INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth Reports Preliminary Q3-2023 Revenues IRVINE, CA, and HERSTAL,
Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
NEWS RELEASE September 26, 2023, 5:00PM EDT / 23:00 CET Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of
MDxHealth Reports Q2 and Half Year 2023 Results
NEWS RELEASE – REGULATED INFORMATION23 AUGUST 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Q2 and Half Year 2023 Results Year-over-year Q2 revenues
MDxHealth annonce la réalisation de sa transition vers une cotation unique sur le Nasdaq
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE18 DECEMBRE 2023, 01:00 ET / 07:00 CET MDxHealth annonce la réalisation de sa transition vers une cotation
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq
NEWS RELEASE – REGULATED INFORMATIONDECEMBER 18, 2023, 1:00 AM ET / 07:00 AM CET MDxHealth Announces Completion of Transition to Single Listing on
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq
NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition
MDxHealth annonce la réalisation de l’échange obligatoire d’ADS et le début de la période de transition vers une cotation unique sur le Nasdaq
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE27 NOVEMBRE 2023, 1:00 EDT / 7:00 CET MDxHealth annonce la réalisation de l’échange obligatoire d’ADS et le début de
MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference
NEWS RELEASENovember 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference IRVINE, CA,
MDxHealth annonce la réalisation de son regroupement d’actions, et la mise à jour des actions et des droits de vote en circulation
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉEINFORMATION PRIVILÉGIÉE13 NOVEMBRE 2023, 16:00 ET / 22:00 CET MDxHealth annonce la réalisation de son regroupement d’actions, et la mise
MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 13, 2023, 4:00 PM ET / 22:00 CET MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding
MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois clôturée le 30 septembre 2023
COMMUNIQUÉ DE PRESSE — INFORMATIONS RÉGLEMENTÉES8 NOVEMBRE 2023, 16 h 00 EDT/22 h 00 CET MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023
NEWS RELEASE – REGULATED INFORMATION8 NOVEMBER 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended
MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET MDxHealth Announces the Approval by its Shareholders of the
MDxHealth annonce l’approbation par ses actionnaires de la proposition de transition vers une cotation unique des actions sur le Nasdaq, ainsi que les détails du regroupement d’actions
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉEINFORMATION PRIVILÉGIÉE6 NOVEMBRE 2023, 1:00 ET / 7:00 CET MDxHealth annonce l’approbation par ses actionnaires de la proposition
MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8
NEWS RELEASE25 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 Company to
Nouveau montant du capital et nouveau nombre d’actions de Mdxhealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE20 octobre 2023, 16:00 EDT / 22:00 CET Nouveau montant du capital et nouveau nombre d’actions de
Mdxhealth’s New Share Capital Amount and New Number of Shares
NEWS RELEASE – REGULATED INFORMATION October 20, 2023, 4:00 PM EDT / 22:00 CET Mdxhealth’s New Share Capital Amount and New Number of Shares
MDxHealth communique ses revenus préliminaires pour le troisième trimestre de 2023
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE ET PRIVILÉGIÉE Le 9 OCTOBRE 2023, 16h00 EDT / 22h00 CET MDxHealth communique ses revenus préliminaires pour
MDxHealth Reports Preliminary Q3-2023 Revenues
NEWS RELEASE – INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth Reports Preliminary Q3-2023 Revenues IRVINE, CA, and HERSTAL,
MDxHealth annonce une proposition de transition vers une cotation unique de ses actions sur le Nasdaq et convoque une assemblée générale extraordinaire des actionnaires
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉEINFORMATION PRIVILÉGIÉELE 2 OCTOBRE 2023, 16h00 EDT / 22h00 CET MDxHealth annonce une proposition de transition vers une cotation unique
MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONOCTOBER 2, 2023, 4:00pm ET / 22:00 CET MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq
Mdxhealth signe une collaboration de recherche avec l’Université d’Oxford pour évaluer la corrélation entre le test GPS et la progression du cancer de la prostate après un traitement pour un cancer de la prostate localisé
COMMUNIQUÉ DE PRESSE 26 septembre 2023, 17h00 EDT / 22h00 CET Mdxhealth signe une collaboration de recherche avec l’Université d’Oxford pour évaluer la
Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
NEWS RELEASE September 26, 2023, 5:00PM EDT / 23:00 CET Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of
MDxHealth communique ses résultats financiers T2 et S1 2023
COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES23 AOÛT 2023, 16 h 00 EDT, 22 h 00 CET MDxHealth communique ses résultats financiers T2 et S1 2023 Les revenus du T2 ont
MDxHealth Reports Q2 and Half Year 2023 Results
NEWS RELEASE – REGULATED INFORMATION23 AUGUST 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Q2 and Half Year 2023 Results Year-over-year Q2 revenues
MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23
NEWS RELEASE10 AUGUST 2023, 4PM ET / 22:00 CET MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on
Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test
NEWS RELEASE9 AUGUST 2023, 4PM ET / 22:00 CET Cigna Expands Commercial and Medicare AdvantageCoverage to Include Mdxhealth’s Select mdx for Prostate Cancer
MDxHealth annonce les résultats de son assemblée générale extraordinaire des actionnaires
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE 30 juin 2023, 2200 CEST MDxHealth annonce les résultats de son assemblée générale extraordinaire des actionnaires IRVINE, CA, et
MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION 30 June 2023, 10:00 p.m. CEST MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting IRVINE, CA, and HERSTAL, BELGIUM –
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION JUNE 5, 2023, 5:30 pm ET/ 23:30 CEST MDxHealth Announces its Extraordinary General Shareholders’ Meeting IRVINE, CA, and
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATION 25 May 2023, 22:30 CET MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings IRVINE, CA, and HERSTAL, BELGIUM
MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference
NEWS RELEASEMay 23, 2023, 4PM ET/ 22:00 CET MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference IRVINE, CA,
MDxHealth Reports Q1-2023 Results
NEWS RELEASE – REGULATED INFORMATION15 MAY 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Q1-2023 Results Year-over-year revenues increase by 141% to $14.7
MDxHealth to Present First Quarter 2023 Financial Results on May 15
NEWS RELEASE 1 MAY 2023, 4PM ET / 22:00 CET MDxHealth to Present First Quarter 2023 Financial Results on May 15 Company to Host
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATIONAPRIL 25, 2023, 4:00 pm ET/ 22:00 CET IRVINE, CA, and HERSTAL, BELGIUM – April 25, 2023 – MDxHealth SA (Nasdaq
Foundational LCD Covers Select mdx for Prostate Cancer
NEWS RELEASE – INSIDE INFORMATIONApril 19, 2023, 4:00PM EDT / 22:00 CET IRVINE, CA, and HERSTAL, BELGIUM – April 19, 2023 – MDxHealth SA (NASDAQ/Euronext:
MDxHealth Shareholder Transparency Declaration
NEWS RELEASE – REGULATED INFORMATION APRIL 7, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – April 7, 2023 – MDxHealth SA
MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
NEWS RELEASE 13 MARCH 2023, 2:00 AM ET / 08:00 CET IRVINE, CA, and HERSTAL, BELGIUM – March 13, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a
MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023
NEWS RELEASE – REGULATED INFORMATION8 MARCH 2023, 4:00 PM EST / 22:00 CET Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March
MDxHealth Announces Update of Outstanding Shares and Voting Rights
NEWS RELEASE – REGULATED INFORMATIONMARCH 8, 2023, 5:00 pm ET/ 23:00 CET IRVINE, CA, and HERSTAL, BELGIUM – March 8, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH)
MDxHealth Announces Exercise of Option
NEWS RELEASE – REGULATED INFORMATIONMARCH 6, 2023, 5:30 pm ET/ 23:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March 6, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth”
MDxHealth Shareholder Transparency Declarations
NEWS RELEASE – REGULATED INFORMATION MARCH 3, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March 3, 2023 – MDxHealth SA
MDxHealth Shareholder Transparency Declaration
NEWS RELEASE – REGULATED INFORMATIONFEBRUARY 21, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – 21 February 2023 – MDxHealth SA
MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
NEWS RELEASEFEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels:
MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
NEWS RELEASEFEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage
MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
NEWS RELEASEFEBRUARY 22, 2023, 4:30pm ET/ 22:30 CET Company to Host Conference Call with Live Q&A, March 8, 2023 at 4:30pm ET/ 22:30 CET IRVINE,
MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
NEWS RELEASEFEBRUARY 22, 2023, 4:30pm ET/ 22:30 CET Company to Host Conference Call with Live Q&A, March 8, 2023 at 4:30pm ET/ 22:30
MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar
NEWS RELEASE – REGULATED INFORMATIONFEBRUARY 15, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 15, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH)
MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar
NEWS RELEASE – REGULATED INFORMATION FEBRUARY 15, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 15, 2023 – MDxHealth SA (NASDAQ/Euronext:
MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test
NEWS RELEASE 13 FEBRUARY 2023, 4:00PM ET / 22:00 CET UnitedHealthcare singles out mdxheath’s GPS test as its only commercially-covered test to risk stratify men
MDxHealth Announces Pricing of Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONFEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET MDxHealth Announces Pricing of Offering of ADSsin the United States IRVINE, CA,
MDxHealth Announces Pricing of Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION FEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET IRVINE, CA, and HERSTAL, BELGIUM – February 3, 2023 – MDxHealth
MDxHealth Announces Launch of Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION FEBRUARY 1, 2023, 4PM ET/ 22:00 CET IRVINE, CA, and HERSTAL, BELGIUM –February 1, 2023 – MDxHealth SA (NASDAQ/Euronext:
MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS Test
NEWS RELEASE –REGULATED INFORMATION 20 JANUARY 2023, 1:00 am ET / 7:00 am CET IRVINE, CA, and HERSTAL, BELGIUM – January 20, 2023 – MDxHealth SA
MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
NEWS RELEASE – INSIDE AND REGULATED INFORMATION 9 JANUARY 2023, 4PM ET / 22:00 CET IRVINE, CA, and HERSTAL, BELGIUM – January 9, 2023 –
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and Resignation of Director
NEWS RELEASE – REGULATED INFORMATION 25 May 2022, 4:00 p.m. EDT / 22:00 CET MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and
Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer
NEWS RELEASE – REGULATED INFORMATIONMay 19, 2022, 4:00PM EDT / 22:00 CET Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx® for
MDxHealth Reports Q1-2022 Results
NEWS RELEASE – REGULATED INFORMATION27 APRIL 2022, 4:00PM EDT / 22:00 CET MDxHealth Reports Q1-2022 Results IRVINE, CA, and HERSTAL, BELGIUM – April
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATION 25 April 2022, 10:00 p.m. CET MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings IRVINE, CA, and HERSTAL, BELGIUM
MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference
NEWS RELEASEMarch 30, 2022, 4:30 PM EST / 22:30 CET MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference IRVINE, CA, and HERSTAL,
MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022
NEWS RELEASE – REGULATED INFORMATION2 MARCH 2022, 4:00 PM EST / 22:00 CET MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance
MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd
NEWS RELEASE 17 February 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
NEWS RELEASE9 FEBRUARY 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
MDxHealth Shareholder Transparency Declaration
NEWS RELEASE – REGULATED INFORMATION 10 December 2021, 23:55 CET MDxHealth Shareholder Transparency Declaration IRVINE, CA, and HERSTAL, BELGIUM – 10 December 2021 – MDxHealth
MDxHealth Shareholder Transparency Declarations
NEWS RELEASE – REGULATED INFORMATION 22 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 22 November 2021 –
MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATION 15 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 15 November 2021 –
MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 8, 2021, 22:30 CET MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States IRVINE, CA, and HERSTAL,
MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATION4 NOVEMBER 2021, 13:00 CET MDxHealth Announces Pricing of Initial Public Offering of ADSsin the United States IRVINE, CA, and
MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATION28 OCTOBER 2021, 07:00 CEST MDxHealth Announces Launch of Proposed Initial Public Offering of ADSsin the United States IRVINE, CA,
MDxHealth Provides Q3-2021 Business Update
NEWS RELEASE – REGULATED INFORMATION21 OCTOBER 2021, 07:00 A.M. CET MDxHealth Provides Q3-2021 Business Update IRVINE, CA, and HERSTAL, BELGIUM – October 21, 2021 –
MDxHealth files Registration Statement for Proposed Initial Public Offering in the United States
NEWS RELEASE – REGULATED INFORMATION13 OCTOBER 2021, 19:30 CET MDxHealth files Registration Statement for Proposed Initial Public Offering in the United States IRVINE, CA, and
MDxHealth Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONSeptember 1, 2021, 18:00 CEST MDxHealth Announces Submission of Draft Registration Statement For Proposed Public Listing in the United
MDxHealth Reports Half Year 2021 Results
NEWS RELEASE – REGULATED INFORMATION26 AUGUST 2021, 18:00 CET MDxHealth Reports Half Year 2021 Results Conference call with Q&A today at 19:00 CET / 1PM
MDxHealth to Present First Half 2021 Financial Results and Corporate Update on August 26
Company to Host Conference Call and Live Q&A Session, August 26, 2021, at 10:00am PT/ 1:00pm ET/ 19:00 CET IRVINE, CA, and HERSTAL, BELGIUM – August
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATION 27 May 2021, 23:00 p.m. CET IRVINE, CA, and HERSTAL, BELGIUM – 27 May 2021 – MDxHealth SA (Euronext Brussels:
